DRUGS-ABOUT.COM

The Anatomical Therapeutic Chemical (ATC) classification system



Level 4

  • L - Antineoplastic and immunomodulating agents
  • L04 - Immunosuppressive agents
  • L04A - Immunosuppressive agents
  • L04AA - Selective immunosuppressive agents

  • L04AA01 - Ciclosporin
  • L04AA02 - Muromonab-CD3
  • L04AA03 - Antilymphocyte immunoglobulin (horse)
  • L04AA04 - Antithymocyte immunoglobulin (rabbit)
  • L04AA05 - Tacrolimus
  • L04AA06 - Mycophenolic Acid
  • L04AA08 - Daclizumab
  • L04AA09 - Basiliximab
  • L04AA10 - Sirolimus
  • L04AA11 - Etanercept
  • L04AA12 - Infliximab
  • L04AA13 - Leflunomide
  • L04AA14 - Anakinra
  • L04AA15 - Alefacept
  • L04AA16 - Afelimomab
  • L04AA17 - Adalimumab
  • L04AA18 - Everolimus
  • L04AA19 - Gusperimus
  • L04AA21 - Efalizumab
  • L04AA22 - Abetimus
  • L04AA23 - Natalizumab
  • L04AA24 - Abatacept
  • L04AA25 - Eculizumab
  • L04AA26 - Belimumab
  • L04AA27 - Fingolimod
  • L04AA28 - Belatacept






  • ATC Classification | Home Page | Sitemap | Terms & Conditions | Privacy Policy | Pharma Doctor | About Us | Contact

    Copyright © 2005-2020 Drugs-about.com. All rights reserved.